B Cheng1, G Broocks2. 1. Klinik und Poliklinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20251, Hamburg, Deutschland. b.cheng@uke.de. 2. Klinik und Poliklinik für Neuroradiologische Diagnostik und Intervention, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20251, Hamburg, Deutschland. g.broocks@uke.de.
Abstract
BACKGROUND: In ischemic stroke due to large vessel occlusion (LVO), the indications for patient selection for endovascular mechanical thrombectomy (MT) are based on findings from brain imaging. Several imaging protocols from computed tomography (CT) or magnetic resonance imaging (MRI) are available to guide treatment decisions. OBJECTIVE: To recommend the optimal choice of imaging modalities and protocols for MT with respect to time windows from symptom onset. MATERIAL AND METHODS: Evaluation of the results of large randomized placebo-controlled trials regarding imaging-based patient selection in MT categorized by time intervals since symptom onset. We discuss methodological aspects, advantages and caveats of individual stroke imaging protocols. Summary of recommendations for the practice. RESULTS AND CONCLUSION: In MT trials CT was mostly used for patient selection. Plain CT combined with CT angiography or additional perfusion imaging is the preferred option. In early time windows CT with CTA is adequate (≤ 6 h for MT, ≤ 4.5 h in cases of accompanying thrombolysis according to exclusion criteria). In later or unknown time windows perfusion imaging is needed for patient selection. Patients presenting with unknown time windows should be examined by MRI as a first-line choice in mild to moderate deficits, in cases of severe deficits CT imaging with perfusion imaging.
BACKGROUND: In ischemic stroke due to large vessel occlusion (LVO), the indications for patient selection for endovascular mechanical thrombectomy (MT) are based on findings from brain imaging. Several imaging protocols from computed tomography (CT) or magnetic resonance imaging (MRI) are available to guide treatment decisions. OBJECTIVE: To recommend the optimal choice of imaging modalities and protocols for MT with respect to time windows from symptom onset. MATERIAL AND METHODS: Evaluation of the results of large randomized placebo-controlled trials regarding imaging-based patient selection in MT categorized by time intervals since symptom onset. We discuss methodological aspects, advantages and caveats of individual stroke imaging protocols. Summary of recommendations for the practice. RESULTS AND CONCLUSION: In MT trials CT was mostly used for patient selection. Plain CT combined with CT angiography or additional perfusion imaging is the preferred option. In early time windows CT with CTA is adequate (≤ 6 h for MT, ≤ 4.5 h in cases of accompanying thrombolysis according to exclusion criteria). In later or unknown time windows perfusion imaging is needed for patient selection. Patients presenting with unknown time windows should be examined by MRI as a first-line choice in mild to moderate deficits, in cases of severe deficits CT imaging with perfusion imaging.
Authors: Gregory W Albers; Michael P Marks; Stephanie Kemp; Soren Christensen; Jenny P Tsai; Santiago Ortega-Gutierrez; Ryan A McTaggart; Michel T Torbey; May Kim-Tenser; Thabele Leslie-Mazwi; Amrou Sarraj; Scott E Kasner; Sameer A Ansari; Sharon D Yeatts; Scott Hamilton; Michael Mlynash; Jeremy J Heit; Greg Zaharchuk; Sun Kim; Janice Carrozzella; Yuko Y Palesch; Andrew M Demchuk; Roland Bammer; Philip W Lavori; Joseph P Broderick; Maarten G Lansberg Journal: N Engl J Med Date: 2018-01-24 Impact factor: 91.245
Authors: Gabriel Broocks; Uta Hanning; Fabian Flottmann; Michael Schönfeld; Tobias Djamsched Faizy; Peter Sporns; Michael Baumgart; Hannes Leischner; Gerhard Schön; Jens Minnerup; Götz Thomalla; Jens Fiehler; Andre Kemmling Journal: Brain Date: 2019-05-01 Impact factor: 13.501
Authors: Ewgenia Barow; Florent Boutitie; Bastian Cheng; Tae-Hee Cho; Martin Ebinger; Matthias Endres; Jochen B Fiebach; Jens Fiehler; Ian Ford; Ivana Galinovic; Alina Nickel; Josep Puig; Pascal Roy; Anke Wouters; Tim Magnus; Vincent Thijs; Robin Lemmens; Keith W Muir; Norbert Nighoghossian; Salvador Pedraza; Claus Z Simonsen; Christian Gerloff; Götz Thomalla Journal: JAMA Neurol Date: 2019-06-01 Impact factor: 18.302
Authors: Jens Fiehler; Mascha Foth; Thomas Kucinski; Renée Knab; Michael von Bezold; Cornelius Weiller; Hermann Zeumer; Joachim Röther Journal: Stroke Date: 2002-01 Impact factor: 7.914
Authors: Bruce C V Campbell; Peter J Mitchell; Timothy J Kleinig; Helen M Dewey; Leonid Churilov; Nawaf Yassi; Bernard Yan; Richard J Dowling; Mark W Parsons; Thomas J Oxley; Teddy Y Wu; Mark Brooks; Marion A Simpson; Ferdinand Miteff; Christopher R Levi; Martin Krause; Timothy J Harrington; Kenneth C Faulder; Brendan S Steinfort; Miriam Priglinger; Timothy Ang; Rebecca Scroop; P Alan Barber; Ben McGuinness; Tissa Wijeratne; Thanh G Phan; Winston Chong; Ronil V Chandra; Christopher F Bladin; Monica Badve; Henry Rice; Laetitia de Villiers; Henry Ma; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis Journal: N Engl J Med Date: 2015-02-11 Impact factor: 91.245
Authors: Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Hester F Lingsma; Albert J Yoo; Wouter J Schonewille; Jan Albert Vos; Paul J Nederkoorn; Marieke J H Wermer; Marianne A A van Walderveen; Julie Staals; Jeannette Hofmeijer; Jacques A van Oostayen; Geert J Lycklama à Nijeholt; Jelis Boiten; Patrick A Brouwer; Bart J Emmer; Sebastiaan F de Bruijn; Lukas C van Dijk; L Jaap Kappelle; Rob H Lo; Ewoud J van Dijk; Joost de Vries; Paul L M de Kort; Willem Jan J van Rooij; Jan S P van den Berg; Boudewijn A A M van Hasselt; Leo A M Aerden; René J Dallinga; Marieke C Visser; Joseph C J Bot; Patrick C Vroomen; Omid Eshghi; Tobien H C M L Schreuder; Roel J J Heijboer; Koos Keizer; Alexander V Tielbeek; Heleen M den Hertog; Dick G Gerrits; Renske M van den Berg-Vos; Giorgos B Karas; Ewout W Steyerberg; H Zwenneke Flach; Henk A Marquering; Marieke E S Sprengers; Sjoerd F M Jenniskens; Ludo F M Beenen; René van den Berg; Peter J Koudstaal; Wim H van Zwam; Yvo B W E M Roos; Aad van der Lugt; Robert J van Oostenbrugge; Charles B L M Majoie; Diederik W J Dippel Journal: N Engl J Med Date: 2014-12-17 Impact factor: 91.245
Authors: Lena-Alexandra Beume; Maren Hieber; Christoph P Kaller; Kai Nitschke; Juergen Bardutzky; Horst Urbach; Cornelius Weiller; Michel Rijntjes Journal: Stroke Date: 2018-10 Impact factor: 7.914
Authors: Friederike Austein; Christian Riedel; Tina Kerby; Johannes Meyne; Andreas Binder; Thomas Lindner; Monika Huhndorf; Fritz Wodarg; Olav Jansen Journal: Stroke Date: 2016-08-09 Impact factor: 7.914
Authors: Bruce C V Campbell; Charles B L M Majoie; Gregory W Albers; Bijoy K Menon; Nawaf Yassi; Gagan Sharma; Wim H van Zwam; Robert J van Oostenbrugge; Andrew M Demchuk; Francis Guillemin; Philip White; Antoni Dávalos; Aad van der Lugt; Kenneth S Butcher; Aboubaker Cherifi; Henk A Marquering; Geoffrey Cloud; Juan M Macho Fernández; Jeremy Madigan; Catherine Oppenheim; Geoffrey A Donnan; Yvo B W E M Roos; Jai Shankar; Hester Lingsma; Alain Bonafé; Hélène Raoult; María Hernández-Pérez; Aditya Bharatha; Reza Jahan; Olav Jansen; Sébastien Richard; Elad I Levy; Olvert A Berkhemer; Marc Soudant; Lucia Aja; Stephen M Davis; Timo Krings; Marie Tisserand; Luis San Román; Alejandro Tomasello; Debbie Beumer; Scott Brown; David S Liebeskind; Serge Bracard; Keith W Muir; Diederik W J Dippel; Mayank Goyal; Jeffrey L Saver; Tudor G Jovin; Michael D Hill; Peter J Mitchell Journal: Lancet Neurol Date: 2018-11-06 Impact factor: 44.182